Berenberg Bank set a €115.00 ($129.21) price target on Gerresheimer (ETR:GXI) in a research note issued to investors on Wednesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

GXI has been the subject of several other research reports. Credit Suisse Group set a €84.00 ($94.38) price target on shares of Gerresheimer and gave the company a buy rating in a report on Tuesday, July 14th. DZ Bank reissued a sell rating on shares of Gerresheimer in a report on Thursday, July 16th. Deutsche Bank set a €105.00 ($117.98) price target on shares of Gerresheimer and gave the company a buy rating in a report on Monday, July 20th. JPMorgan Chase & Co. set a €88.00 ($98.88) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Tuesday, July 21st. Finally, Independent Research set a €82.00 ($92.13) price target on shares of Gerresheimer and gave the company a sell rating in a report on Wednesday, July 15th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of €87.38 ($98.17).

Shares of Gerresheimer stock opened at €97.30 ($109.33) on Wednesday. The firm has a fifty day moving average of €87.94 and a two-hundred day moving average of €73.05. The stock has a market capitalization of $3.06 billion and a price-to-earnings ratio of -96.72. Gerresheimer has a 52 week low of €50.65 ($56.91) and a 52 week high of €100.80 ($113.26). The company has a debt-to-equity ratio of 119.27, a quick ratio of 0.39 and a current ratio of 0.64.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: What defines an oversold asset?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.